Hematologic Oncology Update

Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses...

• 0
• 0
• 2 días

Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from the 2023 ASH Annual Meeting

Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from...

• 0
• 0
• 16 días

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali...

• 0
• 0
• 30 días

Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series

Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses...

• 0
• 0
• 2 meses

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic...

Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff...

• 0
• 0
• 2 meses

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of

Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection...

• 0
• 0
• 3 meses

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of

Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute...

• 0
• 0
• 5 meses

Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of

Dr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas,...

• 0
• 0
• 6 meses

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United...

• 0
• 0
• 6 meses

Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology...

Dr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent...

• 0
• 0
• 6 meses

Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew...

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York,...

• 0
• 0
• 6 meses

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38...

• 0
• 0
• 6 meses

Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm

Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas,...

• 0
• 0
• 7 meses

Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches...

Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of...

• 0
• 0
• 7 meses

What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors

Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New...

• 0
• 0
• 7 meses

Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin...

Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark,...

• 0
• 0
• 7 meses

Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma

Featuring a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr...

• 0
• 0
• 8 meses

Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Par

Dr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and...

• 0
• 0
• 8 meses

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma

Dr Jeremy Abramson from Massachusetts General Hospital in Boston discusses key presentations on...

• 0
• 0
• 8 meses

Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection an

Dr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad...

• 0
• 0
• 8 meses